FDA Approves Controversial Fentanyl-Blocking Drug with Blockchain Ties

The Food and Drug Administration has given “positive feedback” to a new drug called Nalmefene, developed by Tharimmune Inc, which claims to block fentanyl overdose. However, experts say the idea that accidental contact can cause a fatal overdose is largely debunked. The company behind Nalmefene also has ties to the blockchain industry and its business model could impact the development of future drugs.

Source: https://futurism.com/health-medicine/crypto-tharimmune-opioid-drug